Literature DB >> 9389432

Anti-ganglioside GM1 antibody and distal symmetric "diabetic polyneuropathy" with dominant motor features.

Z Milicevic, P G Newlon, G L Pittenger, K B Stansberry, A I Vinik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9389432     DOI： 10.1007/s001250050834

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  11 in total

Review 1.  Beyond glycemia.

Authors:  A I Vinik; Z Milicevic; G L Pittenger
Journal:  Diabetes Care       Date:  1995-07       Impact factor: 19.112

2.  The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests.

Authors:  P J Dyck; K M Kratz; K A Lehman; J L Karnes; L J Melton; P C O'Brien; W J Litchy; A J Windebank; B E Smith; P A Low
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

3.  Quantitative measurement of cutaneous perception in diabetic neuropathy.

Authors:  A I Vinik; S Suwanwalaikorn; K B Stansberry; M T Holland; P M McNitt; L E Colen
Journal:  Muscle Nerve       Date:  1995-06       Impact factor: 3.217

4.  Anti-B-series ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons.

Authors:  T Ohsawa; T Miyatake; N Yuki
Journal:  Neurosci Lett       Date:  1993-07-23       Impact factor: 3.046

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

Review 6.  Diabetic neuropathies.

Authors:  A I Vinik; M T Holland; J M Le Beau; F J Liuzzi; K B Stansberry; L B Colen
Journal:  Diabetes Care       Date:  1992-12       Impact factor: 19.112

7.  IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses.

Authors:  M Ogino; N Orazio; N Latov
Journal:  J Neuroimmunol       Date:  1995-04       Impact factor: 3.478

8.  Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies.

Authors:  D S Younger; G Rosoklija; A P Hays; W Trojaborg; N Latov
Journal:  Muscle Nerve       Date:  1996-06       Impact factor: 3.217

9.  Successful treatment of neuropathies in patients with diabetes mellitus.

Authors:  D A Krendel; D A Costigan; L C Hopkins
Journal:  Arch Neurol       Date:  1995-11

10.  Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy.

Authors:  A I Vinik; S B Leichter; G L Pittenger; K B Stansberry; M T Holland; A C Powers; S Suwanwalaikorn
Journal:  Diabetes Care       Date:  1995-09       Impact factor: 19.112
View more
  4 in total

Review 1.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

2.  Rapidly progressive polyneuropathy due to dry beriberi in a man: a case report.

Authors:  Anthony J Howard; Omesh Kulkarni; Godwin Lekwuwa; Hedley Ca Emsley
Journal:  J Med Case Rep       Date:  2010-12-21

Review 3.  Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus.

Authors:  D Ram Ayyar; Khema R Sharma
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

Review 4.  Diabetic neuropathy.

Authors:  V Bansal; J Kalita; U K Misra
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.